Eugene A Woltering
Overview
Explore the profile of Eugene A Woltering including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
69
Citations
986
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Carter A, Kumar N, Herring B, Tan C, Guenter R, Telange R, et al.
Oncogenesis
. 2021 Dec;
10(12):83.
PMID: 34862365
Pancreatic neuroendocrine tumors (PanNETs) are a heterogeneous population of neoplasms that arise from hormone-secreting islet cells of the pancreas and have increased markedly in incidence over the past four decades....
2.
Jeha G, Boudreaux J, Woltering E, Bren-Mattison Y, Thiagarajan R
Am Surg
. 2020 Aug;
86(11):1575-1576.
PMID: 32731745
No abstract available.
3.
Landry J, Voros B, Ramirez R, Boudreaux J, Woltering E, Thiagarajan R
Ann Surg Oncol
. 2020 Jul;
28(2):751-757.
PMID: 32691337
Background: Appendiceal neuroendocrine tumors (ANETs) are rare neoplasms usually discovered incidentally during appendectomy. ANETs < 2 cm were thought to have no metastatic potential, and this dogma has driven management....
4.
Carter A, Tan C, Pozo K, Telange R, Molinaro R, Guo A, et al.
Proc Natl Acad Sci U S A
. 2020 Jul;
117(31):18401-18411.
PMID: 32690709
Disparities in cancer patient responses have prompted widespread searches to identify differences in sensitive vs. nonsensitive populations and form the basis of personalized medicine. This customized approach is dependent upon...
5.
Thomas K, Voros B, Meadows-Taylor M, Smeltzer M, Griffin R, Boudreaux J, et al.
Cancers (Basel)
. 2020 Jan;
12(1).
PMID: 31947598
Capecitabine and temozolomide (CAPTEM) have shown promising results in the treatment of neuroendocrine neoplasms (NEN). The aim of this study was to evaluate the outcome and role for CAPTEM in...
6.
Wang Y, Chauhan A, Ramirez R, Beyer D, Stevens M, Woltering E, et al.
J Gastrointest Oncol
. 2019 Oct;
10(5):928-934.
PMID: 31602331
Background: Midgut neuroendocrine tumor (NET) patients are often diagnosed at advanced stages with extensive mesenteric nodal and hepatic metastasis. The only potentially curative treatment is surgical tumor eradication. Despite an...
7.
Woltering E, Voros B, Beyer D, Thiagarajan R, Ramirez R, Mamikunian G, et al.
Pancreas
. 2019 Feb;
48(3):356-362.
PMID: 30768573
Objectives: Elevated pancreastatin (PST) levels have been shown to be associated with poor prognosis in small bowel neuroendocrine tumors (NETs). We hypothesized that plasma PST levels that remain elevated following...
8.
Thomas K, Voros B, Boudreaux J, Thiagarajan R, Woltering E, Ramirez R
Oncologist
. 2019 Jan;
24(8):1076-1088.
PMID: 30635447
Poorly differentiated gastroenteropancreatic neuroendocrine carcinomas (GEPNECs) are a rare neoplasm with a bleak prognosis. Currently there are little prospective data available for optimal treatment. This review discusses the current available...
9.
Woltering E, Voros B, Thiagarajan R, Beyer D, Ramirez R, Wang Y, et al.
Pancreas
. 2018 Jun;
47(7):843-848.
PMID: 29939909
Objectives: Elevated neurokinin A (NKA) levels are associated with poor prognosis in patients with small bowel neuroendocrine tumors. We hypothesized that patients with NKA levels that remain elevated despite treatment...
10.
Ramirez R, Beyer D, Diebold A, Voros B, Chester M, Wang Y, et al.
Ochsner J
. 2017 Dec;
17(4):335-340.
PMID: 29230118
Background: Typical and atypical carcinoids represent approximately 2% of all lung tumors. Survival of patients with typical bronchial carcinoids, unlike the survival of patients with most lung tumors, is generally...